Adooq Bioscience

Adooq Bioscience logo

AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.

Company Website

Product Listing

Cabazitaxel 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Cabazitaxel is a semi-synthetic derivative of a natural taxoid. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment

More Information Supplier Page

Cabazitaxel 250mg 250mg  | Purity Not Available

Adooq Bioscience

Cabazitaxel is a semi-synthetic derivative of a natural taxoid. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment

More Information Supplier Page

Cabazitaxel 50mg 50mg  | Purity Not Available

Adooq Bioscience

Cabazitaxel is a semi-synthetic derivative of a natural taxoid. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment

More Information Supplier Page

CaCCinh-A01 10mg 10mg  | Purity Not Available

Adooq Bioscience

CaCCinh-A01 inhibits CaCC currents in human bronchial and intestinal cells. Also inhibits TMEM16A channels (IC50 = 2.1 ??M, in TMEM16A-expressing FRT cells).

More Information Supplier Page

CaCCinh-A01 25mg 25mg  | Purity Not Available

Adooq Bioscience

CaCCinh-A01 inhibits CaCC currents in human bronchial and intestinal cells. Also inhibits TMEM16A channels (IC50 = 2.1 ??M, in TMEM16A-expressing FRT cells).

More Information Supplier Page

CaCCinh-A01 50mg 50mg  | Purity Not Available

Adooq Bioscience

CaCCinh-A01 inhibits CaCC currents in human bronchial and intestinal cells. Also inhibits TMEM16A channels (IC50 = 2.1 ??M, in TMEM16A-expressing FRT cells).

More Information Supplier Page

CAL-101 100mg 100mg  | Purity Not Available

Adooq Bioscience

CAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.

More Information Supplier Page

CAL-101 10mg 10mg  | Purity Not Available

Adooq Bioscience

CAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.

More Information Supplier Page

CAL-101 25mg 25mg  | Purity Not Available

Adooq Bioscience

CAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.

More Information Supplier Page

CAL-101 50mg 50mg  | Purity Not Available

Adooq Bioscience

CAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.

More Information Supplier Page

CAL-130 10mg 10mg  | Purity Not Available

Adooq Bioscience

CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 50mg 50mg  | Purity Not Available

Adooq Bioscience

CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 5mg 5mg  | Purity Not Available

Adooq Bioscience

CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 Hydrochloride 10mg 10mg  | Purity Not Available

Adooq Bioscience

CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 Hydrochloride 50mg 50mg  | Purity Not Available

Adooq Bioscience

CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 Hydrochloride 5mg 5mg  | Purity Not Available

Adooq Bioscience

CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

Calcifediol 10mg 10mg  | Purity Not Available

Adooq Bioscience

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 ??M. It also suppresses PTH secretion and mRNA (ED50=2 nM)

More Information Supplier Page

Calcifediol 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 ??M. It also suppresses PTH secretion and mRNA (ED50=2 nM)

More Information Supplier Page

Calcifediol 25mg 25mg  | Purity Not Available

Adooq Bioscience

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 ??M. It also suppresses PTH secretion and mRNA (ED50=2 nM)

More Information Supplier Page

Calcifediol 50mg 50mg  | Purity Not Available

Adooq Bioscience

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 ??M. It also suppresses PTH secretion and mRNA (ED50=2 nM)

More Information Supplier Page

Calcifediol 5mg 5mg  | Purity Not Available

Adooq Bioscience

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 ??M. It also suppresses PTH secretion and mRNA (ED50=2 nM)

More Information Supplier Page

Calcifediol monohydrate 10mg 10mg  | Purity Not Available

Adooq Bioscience

Calcifediol monohydrate(25-hydroxy Vitamin D3) is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase.

More Information Supplier Page

Calcifediol monohydrate 50mg 50mg  | Purity Not Available

Adooq Bioscience

Calcifediol monohydrate(25-hydroxy Vitamin D3) is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase.

More Information Supplier Page

Calcifediol monohydrate 5mg 5mg  | Purity Not Available

Adooq Bioscience

Calcifediol monohydrate(25-hydroxy Vitamin D3) is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase.

More Information Supplier Page

Calcineurin Autoinhibitory Peptide 1mg 1mg  | Purity Not Available

Adooq Bioscience

Calcineurin inhibitory peptide is a selective inhibitor of Ca2+-calmodulin-dependent protein phosphatase (calcineurin) (IC50 ~ 10 ??M). Does not inhibit PP1, PP2A or CaM kinase II (IC50 > 100 mM).

More Information Supplier Page

Calcineurin Autoinhibitory Peptide 5mg 5mg  | Purity Not Available

Adooq Bioscience

Calcineurin inhibitory peptide is a selective inhibitor of Ca2+-calmodulin-dependent protein phosphatase (calcineurin) (IC50 ~ 10 ??M). Does not inhibit PP1, PP2A or CaM kinase II (IC50 > 100 mM).

More Information Supplier Page